← FDA DRUG APPROVALS

FDA ANDA · ANDA202586

INDIUM IN 111 OXYQUINOLINE

indium in-111 oxyquinoline

Sponsor: BWXT ITG

APPLICATION
ANDA202586
TYPE
ANDA
ORIGINAL APPROVAL
2018-07-25
LATEST ACTION
2018-07-25
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

INDIUM IN 111 OXYQUINOLINEPrescription
INDIUM IN-111 OXYQUINOLINE 1mCi/ML · INJECTABLE · INJECTION

Approval history

2018-07-25UNKNOWN · Original — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →